logo
Plus   Neg
Share
Email

RedHill Biopharma Seeks SEC Review, To Approach FINRA Regarding Suspicious Trading Activity

RedHill Biopharma Ltd. (RDHL), a specialty biopharmaceutical company, announced Tuesday that it is seeking regulatory review by the Securities and Exchange Commission regarding suspicious trading activity including potential naked short selling of its stock.

The company also intends to approach the Financial Industry Regulatory Authority, Inc. or FINRA regarding the same.

RedHill said it engaged with a securities law expert and a forensic investigation firm specializing in trading irregularities and market integrity analysis. The resulting analysis identified trading patterns indicating potentially illegal conduct which warrant scrutiny by the regulatory authorities.

Citing concerns that its shareholders are harmed by various manipulative trading practices, the company vowed to take all appropriate actions to stop further market abuse.

The company added that it will support any resulting regulatory investigation.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The European Commission said Friday that it has signed a deal with Sanofi and GlaxoSmithKline to secure up to 300 million doses of their potential COVID-19 vaccine. Acella Pharmaceuticals recalled certain lots of hypothyroidism medication NP Thyroid in the form of tablets due to super potency, the U.S. Food and Drug Administration said in a statement. The company is recalling one lot of 15mg and one lot of 120mg of NP Thyroid that are packaged in 100 count bottles in strengths of 15 mg, and 120 mg, with expiration dates between October 2020 and November 2020. Walmart announced its decision to raise wages for around 165,000 hourly associates across all its U.S. stores starting October, and introduce a team-based operating model in Supercenters. In a tweet, the retail giant said, "Today we're introducing new leadership roles and cross-training opportunities, giving our associates more ways to grow their careers."
Follow RTT